Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma

European Journal of Endocrinology

Volumn 158, Issue 4, 2008, Pages 551-560

  Bardet, Stéphane ^a   Malville, Elodie ^b   Rame, Jean Pierre ^a   Babin, Emmanuel ^b   Samama, Guy ^b   De Raucourt, Dominique ^a   Michels, Jean Jacques ^a   Reznik, Yves ^b   Henry Amar, Michel ^a  

^a CENTRE FRANÇOIS BACLESSE   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RECOMBINANT THYROTROPIN; THYROID HORMONE;

ADULT; ARTICLE; CANCER INVASION; CANCER SIZE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NECK DISSECTION; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RECURRENCE RISK; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SURGICAL APPROACH; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; ADOLESCENT; AGED; CHILD; FOLLOW UP; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOLOGY; THYROID TUMOR; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS;

EID: 41749090920     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0603     Document Type: Article

References (26)

1. Mazzaferri EL & Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. Journal of Clinical Endocrinology and Metabolism 2001 86 1447-1463.
2. Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, Maurer MS, McIver B, Mullan BP, Oberg AL, Powell CC, van Heerden JA & Goellner JR. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World Journal of Surgery 2002 26 879-885.
3. Scheumann GF, Gimm O, Wegener G, Hundeshagen H & Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World Journal of Surgery 1994 18 559-567.
4. Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R & Belfiore A. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. Journal of Clinical Endocrinology and Metabolism 2004 89 3713-3720.
5. Loh KC, Greenspan FS, Gee L, Miller TR & Yeo PP. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. Journal of Clinical Endocrinology and Metabolism 1997 82 3553-3562.
6. DeGroot LJ, Kaplan EL, McCormick M & Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 1990 71 414-424.
7. Sugitani I, Kasai N, Fujimoto Y & Yanagisawa A. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 2004 135 139-148.
8. Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl DM, Bidart JM, Travagli JP & Schlumberger M. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. Journal of Clinical Endocrinology and Metabolism 2005 90 5723-5729.
9. Hay ID. Papillary thyroid carcinoma. Endocrinology and Metabolism Clinics of North America 1990 19 545-576.
10. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI & Tuttle RM. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006 16 109-142.
11. Pacini F, Schlumberger M, Dralle H, Elisei R, Stair JW & Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. European Journal of Endocrinology 2006 154 787-803.
12. Robbins KT, Clayman G, Levine PA, Medina J, Sessions R, Shaha A, Som P & Wolf GT. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology - Head and Neck Surgery. Archives of Otolaryngology - Head and Neck Surgery 2002 128 751-758.
13. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M & Clark GM. Reporting recommendations for tumor marker prognostic studies (REMARK). Journal of the National Cancer Institute 2005 97 1180-1184.
14. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR & Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993 114 1050-1057.
15. Cady B. Papillary carcinoma of the thyroid gland: treatment based on risk group definition. Surgical Oncology Clinics of North America 1998 7 633-644.
16. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K & Miyauchi A. Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World Journal of Surgery 2006 30 780-786.
17. Tubiana M, Schlumberger M, Rougier P, Laplanche A, Benhamou E, Gardet P, Caillou B, Travagli JP & Parmentier C. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985 55 794-804.
18. Noguchi S, Murakami N, Yamashita H, Toda M & Kawamoto H. Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Archives of Surgery 1998 133 276-280.
19. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H & Takanashi Y. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Annals of Surgery 2003 237 399-407.
20. Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA & Ordonez NG. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. Journal of Clinical Endocrinology and Metabolism 1992 75 714-720.
21. Mazzaferri EL & Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. American Journal of Medicine 1994 97 418-428.
22. Sawka AM, Thephamongkhol K, Brouwers M, Thabane L, Browman G & Gerstein HC. A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. Journal of Clinical Endocrinology and Metabolism 2004 89 3668-3676.
23. Wittekind C, Compton CC, Greene FL & Sobin LH. TNM residual tumor classification revisited. Cancer 2002 94 2511-2516.
24. Leboulleux S, Girard E, Rose M, Travagli JP, Sabbah N, Caillou B, Hartl DM, Lassau N, Baudin E & Schlumberger M. Utrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. Journal of Clinical Endocrinology and Metabolism 2007 92 3590-3594.
25. White ML, Gauger PG & Doherty GM. Central lymph node dissection in differentiated thyroid cancer. World Journal of Surgery 2007 31 895-904.
26. Ohshima A, Yamashita H, Noguchi S, Uchmo S, Watanabe S, Toda M, Koike E, Takatu K & Yamashita H. Indications for bilateral modified radical neck dissection in patients with papillary carcinoma of the thyroid. Archives of Surgery 2000 135 1194-1198.